Latest Biocybernetics Stories
-- Platform Delivers High-Quality Genes Using 10,000-well Silicon-Based Proprietary Platform -- SAN FRANCISCO, April 22, 2015 /PRNewswire/ -- Twist Bioscience, a company focused
Rising concerns over fuel consumption and increasing demand for protein therapeutics are likely to create opportunities for Synthetic Biology Market.
DUBLIN, December 8, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/5mmf77/synthetic_biology) has announced the addition of the "Synthetic
DALLAS, November 25, 2014 /PRNewswire/ -- ReportsnReports.com adds Synthetic Biology Market by Tool (XNA, Chassis, Oligos, Enzymes, Cloning kits), Technology (Bioinformatics,
The synthetic biology market is highly competitive with a large number of players, including both big and small players, operating in this market.
DALLAS, November 19, 2014 /PRNewswire/ -- The report "Synthetic Biology Market by Tool (XNA, Chassis, Oligos, Enzymes, Cloning kits), By Technology (Bioinformatics, Nanotechnology,
LONDON, Oct. 14, 2014 /PRNewswire/ -- Synthetic biology is an emerging biotechnology discipline with a wide range of applications.
San Francisco, Calif., July 14, 2014 /PRNewswire/ -- Synthetic biology company Pareto Biotechnologies today announces a technology partnership with global bioengineering leader DNA2.0, enabling
Report Developed by the Ecological Community Highlights Priority Research Areas WASHINGTON, May 29, 2014 /PRNewswire-USNewswire/ -- Environmental scientists and synthetic
-- Brings Total Funding to $40.2 Million -- SAN FRANCISCO, May 27, 2014 /PRNewswire/ -- Twist Bioscience today announced that it raised $26 million in a Series B financing to commercialize
- A person in a secondary role, specifically the second most important character (after the protagonist).